ADMS — ADAMAS PHARMACEUTICALS INC

Ownership history in GLG LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which GLG LLC reported a position in ADAMAS PHARMACEUTICALS INC (ADMS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.07% (2017 Q3)
Avg. % of fund
0.07%
First filed
2017 Q3
Last filed
2017 Q3
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2017 Q3 INITIATED 47,900 — — 0.07% $1.0M —
% of Fund (quarterly)

Other funds also holding ADMS

As of 2021 Q3 — sorted by position size

Stonepine Capital Management, LLC 3Y 7Y 8.75% AIGH Capital Management LLC 3Y 2.67% Worth Venture Partners, LLC 3Y 7Y 1.39% Opaleye Management Inc. 3Y 7Y 1.34% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 0.8% COOPER CREEK PARTNERS MANAGEMENT LLC 3Y 7Y 0.53% ARMISTICE CAPITAL, LLC 3Y 7Y 0.33% DCF Advisers, LLC 3Y 0.3% HighVista Strategies LLC 3Y 7Y 0.07% MAI Capital Management 3Y 7Y 0.06%
← Back to GLG LLC Holdings